Stroke is one of the leading causes of death and disability worldwide and places a heavy burden on the economy in our society. Current treatment strategies for stroke primarily focus on reducing the size of ischemic damage and on rescuing dying cells early after occurrence. Treatments, such as the use of thrombolytic agents, are often limited by a narrow therapeutic time window. However, the regeneration of the brain after damage is still active days, or even weeks after stroke occurs, which might provide a second window for treatment. Our preliminary data suggests that in vivo delivery of sonic hedgehog (shh) peptide into the CNS of stroke animals improves their functional recovery. We hypothesize that the shh signaling pathway is involved in the regulation of neuroregeneration after stroke and that modulating the shh signaling pathway will lead to better functional outcome in stroke recovery. We will test this hypothesis in a combined pharmacological and genetic approach in an animal model of stroke (middle cerebral artery occlusion MCAo). Towards this goal, we have developed a proposal that consists of three specific aims.
In specific aim 1 and 2, we will investigate the role of the shh signaling pathway in stroke-induced neurogenesis by cell-type specific modification of shh or smo gene in adult neural progenitor cells and local reactive astrocytes.
In specific aim 3, we will test the efficacy of shh- signaling pathway stimulation in a animal stroke model by pharmacological methods. Together, the pharmacological and genetic combined approach of this proposal will generate data that will provide insights on the precise role of shh signaling in the process of injury-induced neuroregeneration. The data gained will be directly applicable to developing novel therapeutic interventions in treating cerebral ischemia through the manipulation of the cellular microenvironment in the CNS. We anticipate that the animal resources and results generated from our study will open new avenues in neuroregeneration research and lead to the identification of molecular therapeutic targets.

Public Health Relevance

Stroke is one of the leading causes of death and disability worldwide and places a heavy burden on the economy in our society. Current treatment strategies for stroke primarily focus on reducing the size of ischemic damage and on rescuing dying cells early after occurrence, which are often limited by a narrow therapeutic time window. The data gained in this research program will be directly applicable to developing novel therapeutic interventions in treating cerebral ischemia through the manipulation of the cellular microenvironment in the CNS in a longer treatment window.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
7R01NS091213-04
Application #
9744412
Study Section
Acute Neural Injury and Epilepsy Study Section (ANIE)
Program Officer
Bosetti, Francesca
Project Start
2018-08-01
Project End
2020-07-31
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Genetics
Type
Schools of Medicine
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Turcato, Flavia; Kim, Paul; Barnett, Austin et al. (2018) Sequential combined Treatment of Pifithrin-? and Posiphen Enhances Neurogenesis and Functional Recovery After Stroke. Cell Transplant 27:607-621
Lu, Tao; Kim, Paul; Luo, Yu (2017) Tp53 gene mediates distinct dopaminergic neuronal damage in different dopaminergic neurotoxicant models. Neural Regen Res 12:1413-1417
Jin, Yongming; Barnett, Austin; Zhang, Yifan et al. (2017) Poststroke Sonic Hedgehog Agonist Treatment Improves Functional Recovery by Enhancing Neurogenesis and Angiogenesis. Stroke 48:1636-1645
Zhou, Xiaofei; Pace, Jonathan; Filichia, Emily et al. (2016) Effect of the sonic hedgehog receptor smoothened on the survival and function of dopaminergic neurons. Exp Neurol 283:235-45
Qi, Xin; Davis, Brandon; Chiang, Yung-Hsiao et al. (2016) Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model. J Neurochem 138:746-57
Guo, Xing; Sun, XiaoYan; Hu, Di et al. (2016) VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington's disease. Nat Commun 7:12646
Filichia, E; Shen, H; Zhou, X et al. (2015) Forebrain neuronal specific ablation of p53 gene provides protection in a cortical ischemic stroke model. Neuroscience 295:1-10
Jin, Yongmin; Raviv, Nataly; Barnett, Austin et al. (2015) The shh signaling pathway is upregulated in multiple cell types in cortical ischemia and influences the outcome of stroke in an animal model. PLoS One 10:e0124657